RayThera
San Diego
About RayThera
RayThera focuses on creating innovative small molecule therapies, particularly in the field of immunology, addressing critical unmet medical needs. The company utilizes decades of drug discovery expertise to enhance the development process while upholding stringent standards.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $110.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2025)
- Website: raythera.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical
Canonical: https://fsome.com/organization/raythera-55876 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.